Global Multiplex Assays Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
MarketResearch.biz delivers in-depth insights on the global multiplex assays market in its upcoming report titled, “Global Multiplex Assays Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global multiplex assays market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global multiplex assays market report has been segmented on the basis of product & service, type, technology, application, end user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
A multiplex assay is any assay that can simultaneously measure multiple analytes in a single cycle. The term multiplex refers to the highest number of analyte measurement per assay. Multiplex assays are widely used in functional genomics, wherein it is primarily used to determine effects of experimental treatments. The main function of multiplex assays is detection of proteins and other biomolecules within a biological sample. Multiplex assays are of two types namely, planar assay and bead-based assay.
Increasing incidence of chronic diseases, especially cancer, wherein multiplex assays are used significantly is a major factor driving growth of the global multiplex assays market. In addition, various benefits of multiplex assays and rapid development in nanotechnology are other major factors expected to boost growth of the global multiplex assays market over the forecast period.
However, high costs associated with procurement and use of multiplex assays is a major factor restraining growth of the global multiplex assays market. Additionally, stringent government regulations for approval of multiplex assays is another major factor expected to hamper growth of the global multiplex assays market over the forecast period.
Currently, the market in North America accounts for highest share in the global multiplex assays market in revenue terms, owing to presence of proper healthcare infrastructure and increasing adoption of multiplex assays in the region. The market in Europe accounted for second-highest revenue share in the global multiplex assays market, due to high healthcare expenditure by governments of countries, and high disposable income, followed by markets in Latin America, Asia Pacific and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing number of patients suffering from chronic diseases, and rise in government initiatives for the improvement of healthcare facilities in the region. Moreover, the markets in Latin America and Middle East & Africa are expected to witness moderate growth over the forecast period. Also, revenue from the market in Middle East & Africa is projected to register a CAGR of X.X% over the forecast period.
Global multiplex assays market segmentation:
By product & service:
- Software & Services
- Protein Assays
- Nucleic Acid Assays
- Cell-based Assays
- Flow Cytometry
- Fluorescence Detection
- Multiplex RT PCR
- Other Technologies (Liquid chromatography–mass spectrometry (LC-MS), dPCR, and colorimetric detection)
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery and Validation
- Clinical Diagnostics
- Infectious Diseases
- Cardiovascular Diseases
- Other Diseases (Autoimmune Disease, Nervous System Disorders, and Metabolism & Endocrinology Disorders)
By end user:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Academic Research Institutes
- Reference Laboratories
- Other End Users (blood banks, CROs, and forensic labs)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Becton, Dickinson and Company
- Meso Scale Diagnostics, LLC.
- Randox Laboratories Ltd.
- Siemens Healthcare GmbH
- Hoffmann-La Roche Ltd.
- Johnson & Johnson Services, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!